CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31,600 | $939,784 | 0.00% |
External links
This page lists CRINETICS PHARMACEUTICALS IN's shareholders in Q3 2023. To view CRINETICS PHARMACEUTICALS IN's shareholder history, click here.